Armed with the new microscope, New Forest Equine Vets (NFEV) has started offering a mobile equine veterinary service, including expert worming advice.
The microscope captures images with a resolution of 1 micron, with a live magnification of x200 and x400 or more, which means that the practice can carry out an accurate egg count in the yard, rather than sending faecal samples off to the lab.
This, they say, allows for a more a more accurate result, because posting faeces can lead to the sample desiccating and the eggs hatching, leading to false negative results. It also allows the veterinary surgeon to give immediate advice and treatment.
Dr. Beth Robinson BVSc Cert AVP(EP) MRCVS, co-owner of NFEV, says "One of the main aims of performing worm egg counts is to identify horses shedding low numbers of eggs so that we can maintain a low number of parasites on the pasture that have not been exposed to wormers and therefore have not been placed under selection pressure for resistance. In horses shedding high numbers of eggs, worm egg count reduction tests are a useful way of assessing whether treatment has been effective."
Andrew Monk, co-founder of ioLight, said: "The product is incredibly simple to use. By using a tablet both the owner and vet can view the image and discuss treatment. We hope that more horse owners in the New Forest will use the services from NFEV to protect their animals, and that it will encourage other equine practices to purchase a microscope so they can also offer a similar high quality service. We have made a video with NFEV to demonstrate their service and encourage other equine vets to use the ioLight microscope in their own mobile clinics."
Beth added: "We are delighted to be working with ioLight and horse owners to keep their animals healthy and improve equine welfare."
The survey is open to all veterinary surgeon members and participants will be entered into a free prize draw to win £500 of BEVA CPD vouchers.
As we all know, antibiotic resistance is increasing throughout human and veterinary medicine, and there are few new antibiotics being produced. As BEVA says, it’s therefore imperative for vets to protect the usage of antimicrobials to maintain their effectiveness for the future.
To that end, the purpose of the survey is to help fill in gaps in knowledge about how antimicrobials are being used and also the current landscape of resistant infections encountered in equine practice.
The survey has been designed by Amie Wilson and Dr Gina Pinchbeck at the University of Liverpool and Tim Mair the incoming President of BEVA.
Tim said: "This survey will assess any changes in prescribing of antimicrobials in equine practice since the last survey in 2009. In addition, we will collect data on the current frequency and types of antimicrobial resistant infections seen by clinicians in all areas of equine practice and what infection control and audit practices are currently using to combat this."
The survey results should lead to a greater understanding of the role of antimicrobial treatment in the overall epidemiology of antimicrobial resistance in horses and will help protect antibiotics for the future of equine and human health.
To take part in the survey, visit: https://liverpool.onlinesurveys.ac.uk/beva-questionnaire-2019-final
The results will be announced to coincide with European Antibiotic Awareness Day on 18 November 2019.
If you have any questions about the survey you can contact the researchers direct: Amie Wilson, University of Liverpool A.wilson3@liv.ac.uk; Dr Gina Pinchbeck, University of Liverpool ginap@liv.ac.uk; Tim Mair, British Equine Veterinary Association tim.mair@btinternet.com
Consistent with previous surveys, lameness was shown to be more likely to be caused by conditions such as osteoarthritis in the limb rather than problems in the foot.
Blue Cross carries out NEHS in May each year in partnership with the British Equine Veterinary Association (BEVA). It is sponsored by Dodson & Horrell and Zoetis and supported by the UK’s leading equestrian organisations and charities.
This year saw a 14% increase in participation compared to 2015, with survey records returned for almost 16,751 horses, ponies, donkeys and mules and 5635 people taking part. Most horses were kept in livery or a private yard and used for leisure and hacking.
Lameness has been consistently seen as the most common syndrome affecting horses in the NEHS results year on year. In the latest survey a total of 32.9% (24.4% in 2015) of horses and ponies with health problems were recorded as lame. Overall, as in previous years, lameness in the limb was more common than lameness caused by problems in the foot.
A breakdown of the types of lameness revealed that 47.4% were recorded as suffering from proximal limb lameness, 31.9% from causes of foot lameness other than laminitis and 20.7% from laminitis. Degenerative joint disease (including foot and proximal limb) was the most frequently reported single cause of lameness (41.2% of all lameness) and the most frequently reported joint affected by DJD was the hock (15.3% of all lameness).
Reports of foot lameness (excluding laminitis) more than doubled this year at 10.5% (4.5% in 2015) of all syndromes reported with pus in the foot being the most frequently recorded problem. This could possibly be attributed to the persistent wet weather during and prior to the survey, which can increase susceptibility to the condition.
Josh Slater from the Royal Veterinary College, who is a member of BEVA’s Health & Medicines Committee and analysed the NEHS data, said: "The data gleaned from the survey remains consistent year on year, confirming the reliability of our findings for benchmarking, referencing and research. This year’s increase in overall lameness may be in part attributed to the higher incidence of pus in the foot but may also be because owners are becoming more aware of lameness issues. Ongoing research on lameness has generated significant media coverage over the past year, helping to raise understanding of the importance of accurate diagnosis and treatment both from welfare and performance perspectives."
The six most notable disease syndromes identified in the 2016 National Equine Health Survey are:
Gemma Taylor, Education Officer at Blue Cross said: "The significant increase in participation again this year shows that owners and keepers of horses are really getting behind the survey and recognising its importance in safeguarding the future health and of the UK’s horses. Over the past year NEHS data has been referred to in leading equestrian and veterinary media, showing its credibility as a valuable benchmarking reference."
The 2016 NEHS survey results are now available. To download a copy visit http://www.bluecross.org.uk/nehs2016results and to register for next year’s survey please visit www.bluecross.org.uk/nehs
Equipalazone is most commonly used to treat lameness in equines and can be prescribed as a treatment for osteoarthritic conditions, acute and chronic laminitis, bursitis and carpitis as well as to reduce post-surgical soft tissue reaction.
The new apple-flavoured version, which contains no added sugar, is presented in 1.5g sachets which are added to feed. The existing unflavoured product is still available as Equipalazone Original.
Dechra Brand Manager Emma Jennings said: “The new apple flavoured Equipalazone is the same tried and trusted popular product that vets have been using for many years but the enhanced apple flavour should improve compliance amongst even the fussiest of feeders.
"Equipalazone has been a best-selling treatment delivering powerful pain relief since we brought it to the market as the first microencapsulated phenylbutazone more than 45 years ago. The new apple flavoured presentation will give vets even more choice when it comes to providing pain relief and anti-inflammatory treatment for equine conditions."
For more information visit www.dechra.co.uk.
The company says it's not just older horses suffering from joint disease, 36% of horses developed the condition by the time they were eight years old.
In the survey, 69% of horses needed up to five visits to their veterinary surgeon for treatment, while 21% needed as many as ten visits. Horse owners spent an average of £2,104 treating their horse’s joint condition while 5% spent more than £7,500 on the problem.
In addition, 53% said they've missed up to ten competitions due to joint disease, with 17% missing more than 20 competitions.
The survey revealed that joint problems are an ongoing concern for many. 76% of owners said they worry about their horse developing osteoarthritis and 30% had retired a horse earlier than expected owing to joint disease. In addition, 84% admitted that they would not buy a horse if they knew it had joint problems.
In terms of joint care, 74% of respondents said they give their horse a joint supplement. 69% check their horse's legs daily and 90% implement post-competition leg care measures.
Cavalor’s Lieselot Hamerlinck said: "It is good to see that so many horse owners are using a joint supplement but it’s important that they understand what to look for when choosing which product to use. They should look for anti-inflammatory products, not just joint support and for clinical evidence on any product claims. It’s not just about giving a joint supplement every day, it’s more about giving the right product tailored to the horse’s individual needs.
"Also horse owners should be mindful that it is equally important, if not more so, to take proper care of their horse’s joints all year round, not just during competition."
For further information, visit www.cavalor.com.
Reference
The threshold values for diagnosis of the disease currently vary dependent on the season, but Waltham says these new findings suggest that diet should also be considered.1
PPID, formerly termed Equine Cushing’s Disease, results from a change in hormone regulation in the pituitary gland, which is situated just below the brain. In healthy equids, the release of some hormones from this gland is controlled through another; dopamine. However, in those with PPID, there is a reduction in the amount of dopamine released. This, in turn, removes the restriction of the hormones from the pituitary gland. One such hormone under this control is adrenocorticotropic hormone, ACTH.
A simple baseline ACTH test is often used to diagnose PPID, with a result above a certain level deemed as positive. However diagnosis is not clear cut as there is a grey area between the threshold for normal and positive results.
Diagnosis can also be challenging because the circulating concentration of ACTH is seasonal, peaking in the Autumn. It is also known to vary with stress, exercise and nutritional state (fasted or fed). When the results lie in the grey zone (between the maximum normal and the minimum disease level), a modified test can be used. This involves measuring the ACTH level before and after administering thyrotropin-releasing hormone (TRH). TRH stimulates the release of hormones from the pituitary gland for all horses. However, the subsequent increase in the circulating ACTH is much greater for those with PPID, even in the early stages of the disease, than healthy animals.
The research investigated the impact of different factors on ACTH levels. Eight senior horses and eight adult horses were all fed grass hay and a rotation of four complementary feed options over seven weeks. The base diet was a low starch and sugar pellet fortified with vitamins and minerals. Horses were fed either the base feed alone or in reduced amounts with one of three options; feeds rich in sugar, starch or fibre. All diets provided the same amount of total energy. The effect of each of these on the ACTH concentrations at specific time points was measured.
As expected, the ACTH in the blood from the senior horses was higher than for the adults. As with previous studies, the level of ACTH was raised in October (Autumn) compared to March, May and August, regardless of age. However, the results revealed that diet can also influence the ACTH levels in horses. The senior horses had much higher levels of circulating ACTH when fed the starch rich diet compared to the adult group at the same time of the year.
Dechra Veterinary Products has launched Celox Veterinary, a product which stops arterial or venous haemorrhage within 3 minutes, described as 'revolutionary' by the company.
Celox Veterinary is available in both a granule formulation and in two sizes of gauze. The granules can be poured into a wound. Once pressure is applied, a clot forms and arterial and venous haemorrhage is stopped within three minutes, independent of the body's normal clotting processes. Celox Veterinary Gauze has the granules ready bonded onto its surface for ease of use.
Dechra says the product works by bonding with red blood cells and gelling with fluids to produce a robust clot which sticks to moist tissue to plug the bleeding site. It can be helpful in treating a wide range of veterinary cases including:
Celox Veterinary is made from chitosan, a natural polysaccharide and by-product of the shrimp industry. It generates no heat while in use and small amounts of residual material left in the body are naturally metabolised.
Dechra Product Manager Rachel Horton said: "Wound care is an area in which Dechra is known for its innovative product range. We are delighted to take this to the next level by offering this revolutionary treatment to vets and believe it will soon establish itself as an efficacious tool when they are faced with significant injuries and severe bleeding."
For further information on Celox Veterinary, please contact your Territory Manager or call Dechra direct on (01939) 211200.
Jon Pycock, President of BEVA said: "A significant number of BEVA members have young children and we want to make it as easy as possible for them to enjoy Congress without having to worry about making separate plans for childcare at home. We have already had a great response to the idea and it’s looking like the crèche is going to be very popular."
The theme of this year's Congress is helping horse vets celebrate the benefits and pleasures of their job.
In addition to the social and scientific programme at Congress, there will be special sessions on reproduction, non-clinical aspects of being a vet, succession planning, a moral maze debate on specials manufacturing and role play demonstrations on how to manage difficult situations in practice.
Dr Juan Samper, Associate Dean for students and instruction at the University of Florida College of Veterinary Medicine will be giving the plenary lecture on the challenges and opportunities in equine practice.
There will also be specific lecture streams for veterinary nurses, equine dental technicians and farriers.
For more information on the BEVA Congress crèche or to reserve your child's place, contact Jocelyn@beva.org.uk or call 01638 723558. BEVA says places are limited so early booking is advised.
The BEVA Congress programme can be viewed at www.bevacongress.org.
The company says the aim is to identify the most effective ways to minimise the risks this common and debilitating infectious equine virus poses. The survey can be found here.
Equine Herpes Virus is a contagious virus, which can cause respiratory disease, abortion and more rarely neurological disease. In addition, sub-clinical infections can be associated with a syndrome of poor performance and have a potential effect on the health of the whole yard.1
The disease is transmitted from horse to horse through the respiratory tract, by inhalation of the viral particles shed by infected horses. Once a horse is infected with Equine Herpes Virus it is likely to be latently infected for life. Viral reactivation and nasal shedding can occur at any time, particularly during stressful periods such as when mixing with other horses at equine events. This can lead to acute disease episodes. Often affected horses are asymptomatic but if they do show symptoms these may include depression, lethargy, pyrexia, nasal discharge and a dry cough. Reduction of shedding through management and vaccination is key to disease control.2
Wendy Talbot, National Equine Veterinary Manager at Zoetis said: "EHV has potentially serious health, performance and financial implications across every sector of the equestrian industry.
"The aim of our survey is to find out more about current vet protocols in practice. The results should help us to identify and then ensure that the most effective prevention strategies are accessible to vets and their clients."
The survey runs from 4 – 22nd March 2019 in parallel to a separate survey for horse owners.
For further information, contact your Zoetis Account Manager or the Zoetis Technical Team on customersupportUK@zoetis.com or 0845 300 9084 choosing option 1.
References
Practices which want to buy the alternative imported vaccine will need to apply to the VMD for a Special Import Certificate (SIC).
Wholesalers have agreed to stock the alternative vaccine.
Zoetis says it acknowledges the concern and frustration this causes its customers and wants to reassure the equine community that it is working hard to resume Equip Rotavirus supply as soon as possible.
For further information, contact your Zoetis account manager or ring Zoetis HQ on 0345 300 8034.
Vets attending the first veterinary-led European Equine Transport Forum, held in Brussels last November, have agreed that the profession needs to take a leading role to help enforce the current regulation governing the long-distance transport of horses, in order for equine welfare standards to be improved.
In support, the British Equine Veterinary Association (BEVA) Trust has announced the introduction of the BEVA Trust Equine Transport Enforcement Award of €1000, to be given annually to the individual or group doing the most to improve enforcement of the current transport regulation.
The Forum was initiated by BEVA President Madeleine Campbell in conjunction with the Federation of Veterinarians of Europe (FVE) and is sponsored by the BEVA Trust and World Horse Welfare. It attracted representatives from 38 nations; including a strong turnout from Eastern Europe where horses sourced for slaughter often start their journeys and Italy which is the end destination for the majority of these horses.
The plight of horses sourced for slaughter was the main focus for discussion and the key issues raised were:
Delegates also examined the long-term need to change the attitude of Italian consumers, raising awareness of the current welfare issues related to their preference for fresh meat, labelled as Italian produce. In addition they discussed the impact on equine welfare of increased profits in sourcing horses in Eastern Europe and then transporting them long distances for slaughter.
Dr Madeleine Campbell said: "The atmosphere throughout the day was one of collaboration and determination to succeed. Proper enforcement of the current regulation is the key to welfare improvements, as is the need for a system of best practice to drive a change in cultural attitudes about how horse meat is produced. A process of education is necessary so that consumers understand the welfare issues associated with long-distance transport and start demanding accurate information about where the meat which they are buying originally came from, and how far the horses travelled to slaughter. We are all in agreement that vets have a pivotal role to play in both education and enforcement, and that they want to play it."
Nominations for the annual BEVA Trust Equine Transport Enforcement Award are open and can be made via the FVE and the BEVA Trust. The award will be judged by the FVE Working Group on Transport, and will be awarded for the first time in November 2011. The programme, abstracts and presentations from the Forum can be found at: http://www.fve.org/events/index.html#conferences
The Investigating Committee and the Disciplinary Committee are responsible for conducting desk-top investigations and disciplinary hearings in response to complaints, disclosures and notifications that may amount to serious professional misconduct by Registered Farriers.
As the Royal College of Veterinary Surgeons did in 2015, the FRC is splitting off its disciplinary functions from that of its Council, meaning it now needs to recruit new members to perform the role.
More information is available in VetSurgeon Jobs, here.
B&W operates an integrated practice based around a multi-disciplinary referral hospital in Breadstone, Gloucestershire, with additional clinics in Cardiff, Gloucestershire and Bristol. The group employs more than 30 veterinary surgeons, including seven diploma holders, and offers a full range of services, including what it says is the most comprehensive equine imaging service in the UK.
Ian Camm, Managing Director of B&W, will continue in the role of Equine Regional Director for the South West at CVS. He said: "We are excited about life within CVS and see many opportunities for our staff both within B&W and within the wider Equine Division at CVS. We look forward to working with the CVS team to realise the potential the partnership offers to members of our team and to further developing B&W as an equine veterinary centre of excellence."
Simon Innes, Chief Executive at CVS, said: "Our Equine Division has grown rapidly over the last 18 months because we offer an ambitious and exciting vision for the future of equine practice. B&W is one of the UK’s premier equine practices and we are delighted to welcome the team to CVS and look forward to working with them to help them build an even more successful future."
SPVS is leading a ground-breaking new project which aims to find out how veterinary surgeons are treating a range of clinical conditions.
Two hundred practitioners are being sought to provide details of how they address clinical conditions in three study areas: small animal, equine and farm animal, on a new website: www.howdoido.org. The findings, which will be made anonymous, will eventually form the basis of a clinical benchmarking process, which will tie in with the growing trend towards evidence-based medicine.
SPVS's objective is to understand and support how clinicians work in practice and approach particular clinical cases. The Society is working alongside Dr Mark Johnson who carried out the Confidential Enquiry into Perioperative Equine Fatalities.
SPVS Junior Vice President Jacqui Molyneux said: "This is an exciting new study which will shed a lot of light on what we as clinicians are doing in practice with the eventual aim of developing a clinical benchmarking process.
"The project however will only be worthwhile if a significant number of practitioners take part, so we're encouraging vets to visit the website and find out more. It will take no longer than ten minutes to fill in each clinical case."
The survey will assess vets’ experiences of the disease, biosecurity and the role of vaccination to help prevent strangles.
It includes questions on the number of strangles cases diagnosed in the last year, how the diagnosis was reached and in what instances they would recommend strangles vaccination.
The survey, which is approximately two minutes long, is at: https://forms.office.com/e/wH1UeVFmVW.
All participants will be entered into a prize draw for a £50 Amazon voucher.
For further information on Strangles Awareness Week: https://www.redwings.org.uk/strangles/strangles-awareness-week.
Saliva was collected from 237 horses at the UK welfare charity, Bransby Horses, where EquiSal Tapeworm saliva testing was used to inform on anthelmintic administration over the course of a year. This diagnostic-led approach reduced the use of anti-tapeworm treatments by 86% compared to 6 monthly interval treatment strategies.
Austin Davis Biologics Ltd, the maker of the EquiSal Tapeworm saliva test, says it accurately diagnoses horses with a tapeworm infection, providing a low, borderline or moderate/high diagnosis.
Treatment is recommended for horses with a borderline or moderate/high result2.
In this latest study, the company says most horses diagnosed below the treatment threshold in the first saliva test remained below the threshold in the following two tests and 168 horses (71%) required no anti-tapeworm treatment at all.
Importantly, no increase in tapeworm infection prevalence was observed during the study period and only seven horses received treatment following all three saliva tests, suggesting that some horses are more susceptible to tapeworm infections.
The EVJ has prepared a podcast summarising the study findings here: https://evj.podbean.com/e/evj-of-the-hoof-podcast-no-1-march-2018-use-of-saliva-based-diagnostic-test-to-identify-tapeworm-infection-in-horses-in-the-uk/.
The study authors have also prepared a video abstract which can be viewed at https://vimeo.com/254338616 .
EquiSal saliva collection kits are available at trade prices to veterinary practices and SQPs. Contact enquiries@equisal.com or visit www.equisal.com for more information.
The new website explains what Veterinary Specialists are, how they may be able to help, and how the referral process works. The BCVSp says it has been designed to be a useful resource which primary practices can direct their clients to if a referral is being considered.
As well as being able to search for a Specialist by location and by discipline, owners can also read some real life patient case studies following the referral, treatment journeys and outcomes of animals that have benefited from Specialist care and meet some of the Specialists via podcast links.
BCVSp Trustee Celia Marr said: "While most happy healthy animals will never need Specialist veterinary care, if they do we want their owners to know that we are here to help.
"There are many hundreds of Specialists working at the forefront of veterinary care and also those working in research, pathology and academia, helping to advance animal health and welfare, every day. We believe our new website should help to spread the word and make referral more understandable and accessible."
Visit the new website at www.yourvetspecialist.org
Vetoquinol is introducing Equistro Kerabol Biotin, a complementary feeding stuff for horses which the company says can help maintain healthy hoof and hair growth when used daily.
Equistro Kerabol Biotin will replace Biometh Z and will be automatically supplied in its place when wholesaler stocks of Biometh Z are exhausted.
Equistro Kerabol Biotin is a complex of D-biotin, methionine and Ipaligo zinc in combination with organic selenium and Ipaligo manganese.
Available as a powder in a 3kg bucket which will last 200 days, Vetoquinol says Equistro Kerabol Biotin offers a cost-effective method of ensuring good quality hoof horn.
For more information about any Equistro product, please call 0800 169197 or speak to your local equine territory manager.
Sarah is a Professor of Veterinary Surgery at the University of Nottingham’s School of Veterinary Medicine & Science, and leads the Nottingham Equine Colic Project, which works with organisations such as the British Horse Society to raise awareness of the condition.
Sarah's talk, 'Generating an evidence-based educational campaign on colic', will discuss new evidence from the project, and how it led to the REACT colic campaign. She will also be sharing experiences of how the campaign has worked and asking whether we can change people's attitudes and behaviours.
The evening starts at 6.15pm with food and refreshments with Sarah's talk starting at 7pm, after which there will be an update on the College’s latest projects and initiatives. That'll be followed by a question and answer session with senior officers and staff from the RCVS - including RCVS President Dr Niall Connell, and Chair of RCVS Veterinary Nurses (VN) Council Racheal Marshall.
Dr Connell said: "Thank you to Professor Freeman for agreeing to speak about the colic project which, through its Colic Awareness Week, is helping to raise knowledge of the early signs of colic amongst horse owners, allowing them to get their horses treated in good time and saving their lives.
"I also look forward to talking to members of the profession about some of the issues currently on their minds – the evening is very much led by what those who attend want to discuss – from mental health, to our under care review, to the Practice Standards Scheme. Attending the event can also count to up to three hours towards your continuing professional development (CPD) requirement."
The event is open to all members of the practice team including veterinary surgeons, veterinary nurses, practice managers and others. The event is free and places can be booked via the RCVS website at www.rcvs.org.uk/nottingham.
In the afternoon before the event, between 12 noon and 5pm, the College will also be holding a series of free 45-minute Practice Standards Scheme (PSS) surgeries with PSS Lead Assessor Pam Mosedale.
The surgeries are open to both RCVS-accredited practices and those considering joining the Scheme and allows delegates to discuss the assessment process, how to apply for awards, how to meet particular requirements and any other questions they may have about the PSS.
Places at the surgeries are limited and will be allocated on a first-come, first-served basis. They can be booked at: www.rcvs.org.uk/PSSsurgeries
Gil Riley of the Pool House Veterinary Hospital in Lichfield, Staffordshire has won the annual Petplan Equine Vet of the Year Award.
The Award was announced at the 21st annual Animal Health Trust (AHT) Equestrian Awards gala dinner held at the Lancaster Hotel in London last Thursday.
Horse owners from all over the UK nominated vets who had gone above and beyond the call of duty. A short list of three finalists was then drawn up and the winner selected by an independent panel consisting of: Peter Webbon AHT Chief Executive and Equine Vet, Alison Bridge Editor-in-Chief of Horse & Rider Magazine, Chris House President of the British Equine Veterinary Association (BEVA) and Jo Whitaker Marketing Development Manager for Petplan.
Peter Webbon of the AHT said "We received a record number of nominations this year and the standards were incredibly high. However, Gil was nominated by over 100 clients and we felt he was truly deserving of this award."
Alison Andrew, Marketing Manager for Petplan said: "This award recognises the amazing hard work and commitment of people within the equine veterinary profession and those who provide outstanding service to horse owners."
Gil joined the Pool House Veterinary Group and Equine clinic practice to expand his equine skills after working in a mainly agricultural practice in Wales and is jointly responsible for the Equine part of the Practice. He has subsequently been awarded the Royal College of Veterinary Surgeons Certificate in Equine Practice and he is particularly interested in lameness and laminitis. He also recently acted as British Team Vet at the International Driving Trials in Germany.
Gil said: "Everyday I feel like I'm pulling the greatest trick in that I get paid for doing what I love. To receive further recognition with this award almost feels greedy. I'm tremendously flattered and indebted to all my clients who nominated me."
In his acceptance speech Gil praised his team for their dedication and support without whom, he said this would not have been possible. Special thanks went to his proud wife Emma on the evening of their fifth wedding anniversary.
The Animal Health Trust Equestrian awards are designed to recognise the outstanding achievements made by horses, riders, owners and trainers throughout the equestrian world. Since the Petplan Charitable Trust was founded in 1994 it has raised over £5million, almost £500,000 of which has been donated to the AHT to fund research and development.
Mark Bowen, Associate Professor at The University of Nottingham, has been appointed as President of the British Equine Veterinary Association (BEVA) for 2015/16.
Mark will take over the role from Andrew Harrison at the end of BEVA Congress on 12th September. Vicki Nicholls, Veterinary Assistant at Wright and Morten Vets, Cheshire becomes President Elect.
He said: "BEVA’s strengths lie in its members, who are committed to the welfare of the horse and the advancement of clinical practice. With new benefits for members, a new website, a new role for the BEVA Trust and the highest quality of education, BEVA is now an even more forceful and effective voice for the equine profession, both internally and externally.
"Whilst the profession attempts to shape its future for the next 15 years, we must continue to support the innovative individuals in the profession who look ‘outside the box’ and make sure that the future of our profession, the next generation of veterinary surgeons, does not become restricted by dogma and tradition; that they too can replicate the level of innovation seen in equine practice over the last 50 years.
"It is vital that we continue to strengthen our relationships with the British Horseracing Authority and contribute to the development of a funding body to replace the Horserace Betting Levy Board. Our relationship with the BVA, the regulation of allied professionals, the rescheduling of ketamine, the new EU animal health regulations and EU medicines regulations, even the role of Europe, are key areas where BEVA will make veterinary voices heard for the benefit of equine welfare.
"Lastly, employment and retention of veterinary graduates in the profession is a cause of concern to us all. Over the next year we will enhance the Internship Awareness Programme and provide support and mentoring for the younger members of the profession. BEVA council is full of individuals committed to working on your behalf and I am looking forward to working alongside them all for the benefit of us all."
There are three awards on offer: two ruminant bursaries and one companion animal bursary. Applications must be in by 30th November 2018.
Each project should be completed within one to two years and the vet practitioner proposals will be judged by university academics to ensure independent assessment.
The companion animal research bursary will be assessed by the University of Nottingham Centre for Evidence-based Veterinary Medicine and the ruminant research bursary applications will be assessed by academic staff from the University of Bristol School of Veterinary Science.
Michelle Townley, veterinary advisor at MSD Animal Health (pictured right) said: "New knowledge and good research skills form the lifeblood of the industry so we’re keen to get as many applications as possible as part of our commitment to encouraging research in the veterinary industry."
For further details go to the MSD Animal Health Research Bursary website: www.msdahresearchbursary.co.uk.
Currently used by more than 200 practices and 50 universities around the world, the Equinosis Q is a diagnostic tool that can further aid the subjective lameness evaluation on all types of horses and ponies examined in the field or in hospital settings.
Christina Frigast, MRCVS, Eickemeyer Product Development Manager said: "The inertial sensors sample 20x faster than the human eye making the Equinosis Q a valuable tool to the veterinarian in the evaluation of subtle and multiple limb lameness.
"It does not interfere with the routine lameness examination as trot up on straight line, lunging and ridden evaluations can be performed on both hard and soft surfaces.
"Data is wirelessly streamed to a tablet PC and compiled into a reader-friendly report displaying the timing and severity of lameness. The effectiveness of diagnostic blocks can also be assessed with the Equinosis Q, providing the veterinarian with a percentage of improvement. In addition, comparison reports can be used to monitor rehabilitation progress."
Contact Eickemeyer to book a free demo, or for further information, visit: https://www.eickemeyer.co.uk/Diagnostics-and-Education/Anatomy-Models/Lameness-Locator-vet.html?listtype=search&searchparam=lameness
watch?v=MS6UXQSq6q0
In short, it's a way for equine vets, researchers and students to stay on top of the latest research without accumulating towering stacks of unread journals.
Early reaction to the publication has been very positive. Professor Renate Weller at the Royal Veterinary College said: "HoofSearch is a great tool for anybody interested in staying up to date with what work is going on in relation to horse feet. It is a trustworthy source at an affordable price.
Renate added: "I am not the only one who appreciates HoofSearch; the farriers enrolled in our new degree in research are also using it for their work."
RVC Structure and Motion Laboratory PhD candidate Amy Barstow, BVetMed (Hons), agreed: "HoofSearch gives you a straightforward, time-efficient way to stay on top of the latest research."
Michigan State University College of Veterinary Medicine Professor Emerita Hilary M. Clayton also endorses the new publication. She said: "HoofSearch is worth its weight in gold – instead of spending countless hours scouring the literature, I just go through HoofSearch each month and find all the new publications, proceedings and patents neatly classified and enough of the abstract to convey the contents of the article."
Publisher Fran Jurga said: "Everywhere professionals are involved in helping horses with foot problems, the push is on to both be able to access and build on a comprehensive, if still evolving, body of knowledge. These reports will be useful to track how this newly expanding field of research grew and contributed to the improved welfare, longevity and soundness of horses in the future. I can’t wait to add more editions on other equine health subjects."
A subscription to HoofSearch is US$119, worldwide, for 12 editions.
For more information, visit: https://goo.gl/hJTISt
To subscribe (outside the US), visit: https://www.paypal.me/Hoofcare/119
This year the event delivered more than 90 hours of CPD lectures, workshops and practicals across six separate streams, over three days. Over 100 veterinary industry leaders showcased their wares in the commercial exhibition hall and there were a number of social events for delegates.
Delegates awarded the scientific programme an average score of 4.7 out of 5 stars, and 94% of delegates said they will put what they learnt into practice and use it in their day-to-day role. 94% also said Congress was good value for money.
Swissvet, a company which makes power dentistry equipment, won the Veterinary Practice Best New Exhibitor Award. CEO Dr Ruedi Steiger said: We have distributors throughout Europe, but it is the first time Swissvet has exhibited at BEVA. It has been a fantastic experience and I am thrilled to have won this award. I definitely plan to come back next year."
Next year’s BEVA Congress will be held in Birmingham from 9-12 September 2020. For further information visit www.beva.org.uk.
Photo: David Boughey